Amoy Diagnostics (300685.SZ) has completed its repurchase, spending a total of 101 million yuan to repurchase 1.35% of its shares.

25/02/2025

GMT Eight

Amoy Diagnostics (300685.SZ) announced that the share repurchase plan has been completed. As of February 25, 2025, the company has repurchased a total of 5.3748 million shares through centralized bidding trading, accounting for 1.35% of the current total share capital. The total transaction amount is 101 million yuan (excluding trading fees).

3 consecutive boards Dawei Technology (Guangdong) Group (600589.SH): The company mainly engages in IDC business and its main business has not undergone major changes.

5 consecutive boards Shenzhen Zowee Technology(002369.SZ): The company's products have not been applied in the field of AI glasses, and no relevant agreements or orders have been signed.

Contact: contact@gmteight.com

Amoy Diagnostics (300685.SZ) has completed its repurchase, spending a total of 101 million yuan to repurchase 1.35% of its shares.

RECOMMEND

BIOSTAR PHARM-B (02563) included in Hang Seng Composite Index constituents.

Chinese technology stocks may have stopped falling? Overseas institutions: the pullback brings a good buying opportunity.

Hong Kong Land Department: SHK PPT (00016) successfully bid for the Sha Tin land for 606 million Hong Kong dollars.